Liontown Selects InEight Document to Support Mining Project Information Management Orphazyme to present at upcoming investor conferences
Orphazyme A/SInvestor news No. 05/2021Company Registration No. 32266355 Copenhagen, Denmark and Chicago, IL, USA, April 27, 2021…
Athenex to Provide Corporate and Financial Update for the First Quarter 2021 on May 6, 2021
BUFFALO, N.Y., April 27, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference
SEATTLE, April 27, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage…
Tarsus Pharmaceuticals, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference
IRVINE, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late…
Myriad Genetics to Release March 2021 Quarterly Financial Results on May 3, 2021, Host Investor Day on May 4, 2021
SALT LAKE CITY, April 27, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a…
BioVie Acquires Biopharma Assets from Privately Held NeurMedix
Includes Pivotal Phase 3 Alzheimer’s Asset NE3107 Cuong V. Do Named CEO of The New…
Leading BioSciences Closes Merger with Seneca Biopharma and Set to Begin Trading on Nasdaq as PALI
The combined company, Palisade Bio, Inc., is expected to commence trading on the Nasdaq Capital…
Gain Therapeutics to Present at the B. Riley Securities’ Virtual Neuroscience Conference
BETHESDA, Md., April 27, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) a…
Y-mAbs Submits Omburtamab Marketing Authorization Application to the European Medicines Agency
NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq:…
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
– Granted Priority Medicines designation by the European Medicines Agency for CTX001™ for transfusion-dependent beta…
Aligos Therapeutics Appoints James Scopa, J.D., MBA, to its Board of Directors
SOUTH SAN FRANCISCO, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Iovance Biotherapeutics to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 6, 2021
SAN CARLOS, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Santhera Reports End Results on Convertible Bond Exchange Offer
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL…
Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
Apabetalone treatment was associated with a 52% hazard reduction for MACE events such as CVD…
CORRECTION: Composition of the Nomination Committee of Orion Corporation
ORION CORPORATION STOCK EXCHANGE RELEASE 27 APRIL 2021 at 19.50 EEST CORRECTION: Composition of the Nomination…
Sorrento Receives FDA Clearance to Proceed With Phase 2 Study for Sti-3031, an Anti-Pd-L1 Antibody, for Advanced Urothelial Carcinoma
STI-3031 was discovered from Sorrento’s fully human G-MAB™ library. Currently, six G-MAB antibodies are in Phase…
Tricida to Report First Quarter Financial Results and Host Conference Call and Webcast on Thursday, May 6, 2021
SOUTH SAN FRANCISCO, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA) today announced…
Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 Results
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company…
BeyondSpring to Announce Fourth Quarter and Year End 2020 Financial Results and Host a Conference Call on Friday, April 30, 2021
NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ:…
Composition of the Nomination Committee of Orion Corporation
ORION CORPORATION STOCK EXCHANGE RELEASE 27 APRIL 2021 at 18.20 EEST Composition of the Nomination Committee…